Science is our Nature TM

Similar documents
Global EHS Resource Center

Pharmaceutical, Medical and Health-related Government and Regulatory bodies around the world.

EUROPEAN AEROSOL PRODUCTION

GLP in the European Union Ecolabel detergents, GLP and accreditation

Chemical compatibility of the Pall QPoint TM Docking Station - Tap Assembly with common surface disinfectants

EPIDEMIOLOGY. Accurate, in-depth information for understanding and assessing targeted markets

The Company. Beyond Pioneering

Because you care about CONSUMERS HEALTH

A GLOBAL LEADER IN PERSONALIZED NUTRITION

SYNERGISTIC BLENDS OF NATURAL POLYPHENOLS

ANIMAL HEALTH DIVISION. Technologies & Services

Request for Letters of Intent. International Development of H5N1 Influenza Vaccines

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers

Boehringer Ingelheim BioXcellence. Producing Value. Global Contract Manufacturing Excellence

Sirtex Medical Limited (ASX:SRX)

about us Cyndea Pharma independent

Reyssouze, France Milan, Italy Palafolls, Spain

Allied Health: Sustainable Integrated Health Care for all Australians

Terms and Conditions. VISA Global Customer Assistance Services

MediCult. DnB NOR 2008 Health Seminar. Life s Beginning in Safe Hands

THE COMPLEX JOURNEY OF A VACCINE PART I The manufacturing chain, regulatory requirements and vaccine availability

38 COUNTRIES. Company Overview. Over 290,000 cases Implanted Worldwide. In-house Manufacturing. International Distribution.

Tobacco Insights May

Performance against the USLP global nutrition targets in key countries 2017

Stax Disposable Depth Filters

Global Terephthalic Acid (PTA) Market Study ( )

Proton Therapy Market Outlook - Global Analysis

THE GLOBAL HEALTH SECURITY AGENDA. We have to change our mindsets and start thinking about biological threats as the security threats that they are.

PRODUCT DECLARATION. Purolite C100MRNS. This declaration was prepared by Purolite Corporation in February, 2017.

OPENING UP A NEW WORLD

FOURIER STUDY GREYLOCK PRESS: CTS PRODUCT SAMPLE - FOURIER YES. Did the study achieve its main objective?

PRODUCT DECLARATION. Purolite A430MR. This declaration was prepared by Purolite Corporation in February, 2017.

Consumer Health Care V5.0_2013

040716_ANDI_VENTIS WEBSITE(new) Printout 1. HOME PAGE. Welcome to our world of Dry Powder Inhalers!

MARKET NEWS for pig meat

Injection Techniques Questionnaire (ITQ) WorldWide Results Insulin Usage

For personal use only

Global Polybutylene Terephthalate (PBT) Market Study ( )

A New Era in SFC Column Technology

Recommended composition of influenza virus vaccines for use in the 2007 influenza season

Injection Techniques Questionnaire (ITQ) WorldWide Results Needle Gauge

Leader in custom manufacturing. for the pharmaceutical and nutraceutical industries.

Innovator in Chelated Mineral Nutrition

Main developments in past 24 hours

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

Good Laboratory Practice. EU-Serbia screening meeting Brussels, 19 June 2014

Cardiac Assessment Controls

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link. Fully-Automated HbA 1c Testing

Cardiac Assessment Controls A critical element of reliable cardiac testing

- Network for Excellence in Health Innovation

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

Type 1 Diabetes Australian Research Impact Analysis

Bio-Rad Laboratories HEMOGLOBIN Testing Bio-Rad A1c. VARIANT II TURBO Link System. Fully-Automated HbA 1c Testing

The next best thing to fruits and vegetables

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Schedule of Accreditation issued by United Kingdom Accreditation Service 2 Pine Trees, Chertsey Lane, Staines-upon-Thames, TW18 3HR, UK

PRODUCT DECLARATION. Purolite C115KMR. This declaration was prepared by Purolite Corporation in February, 2017.

Global Zinc Chemicals Market Study ( )

CND UNGASS FOLLOW UP

Boehringer Ingelheim Biopharmaceuticals in China. Your Reliable Contract Manufacturing Solution Provider

Sperm donation Oocyte donation. Hong Kong þ Guideline þ þ Hungary þ þ þ þ Israel þ þ þ þ Italy þ þ þ. Germany þ þ þ þ Greece þ þ þ þ

Undetectable = Untransmittable. Mariah Wilberg Communications Specialist

THE CARE WE PROMISE FACTS AND FIGURES 2017

Your Partner in Healing

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

D7.1 Report summarising results of survey of EU countries to identify volumes and trends in relation to the import and export of stem cells

Country-wise and Item-wise Exports of Animal By Products Value Rs. Lakh Quantity in '000 Unit: Kgs Source: MoC Export Import Data Bank

World Connections Committee (WCC) Report

THE ISSUE. How will this situation adversely impact on the consumer, trade and the future acceptance of TCM?

An increasing demand for livestock directly translates into increasing demand for animal feed and animal

Novel low-calorie bulk sweeteners

Global review of the challenges in use of traditional medicine and WHO perspective

MIRTOSELECT A NEW VALIDATED HPLC METHOD OF ANALYSIS. mirtoselect. product

Tobacco: World Markets and Trade

WELLNESS COACHING. Wellness & Personal Fitness Solution Providers NZ & Australia

Corporate Overview. beyond pioneering

More information at

Infectious Disease Testing. ULTRA Product Line. Safety is not a Matter of Chance

BioPlex 2200 Infectious Disease Panels

Medicinal Marihuana Science, Redefined

o Dental Implants Market By Material, Type, Structure Global Forecast To 2022 Report ID: MRDH Publishing Date: July, 2017

NobelProcera Implant Bar Overdenture complete range of fixed and removable solutions.

The first and only fully-automated, multiplexed solution for Measles, Mumps, Rubella and Varicella-zoster virus antibody testing

Molecular Diagnostics Market Share, Size, Analysis, Growth, Trends and Forecasts, 2016 to 2024 Hexa Research

WCPT COUNTRY PROFILE December 2017 SWEDEN

Immunohematology. IH-QC Modular System. Select. Combine. Control.

NobelProcera Implant Bar Overdenture EXPERIENCE THE NEW WORLD OF CAD/CAM DENTISTRY

MARKET NEWS for pig meat

WCPT COUNTRY PROFILE December 2017 HUNGARY

Citric Acid. The Citric Part of Life. Lemon Juice and Fermentation Technology

COMMITTEE OF EXPERTS ON THE CLASSIFICATION OF MEDICINES AS REGARDS THEIR SUPPLY (CD-P-PH/PHO) PROGRAMME RESULTS

Medical Developments International

WCPT COUNTRY PROFILE December 2017 SERBIA

Transcription:

full screen TM

OUR MISSION At Indena we believe that an in-depth knowledge in active ingredients derived from medicinal plants and the search for excellence at all times are crucial commitments to serving our customers in pharmaceuticals, health foods and cosmetics. Research and production technologies are the main focus of our mission and the way we create a value difference for our partners. And we ve got more than 80 years of experience to prove it.

COMPANY OVERVIEW A privately owned Italian company founded in 1921, Indena originally focused on extracts from medicinal plants for galenic preparations. INDENA TODAY IN FIGURES 700 employees 4 6 40 4 sales branches in the world 6 production sites in the world sales in over 40 countries

THE INDENA MARKET Indena pursues excellence with the goal of being recognised within the botanical derivatives sector as the partner of choice for companies offering their customers innovative products. THREE BUSINESS SECTORS HEALTH FOOD 30% MAJOR MARKETS COSMETIC 5% PHARMACEUTICAL 65% FRANCE 15% USA 30% ITALY 12% GERMANY 10% JAPAN 8% others

INDENA: A PROACTIVE VOICE Indena s experts constantly communicate and interact with the major international REGULATORY AUTHORITIES: EMEA - European Agency for the Evaluation of Medicinal Products European Pharmacopoeias ESCOP - European Scientific Cooperative on Phytotherapy Italian Pharmacopoeia NCCAM - National Centre for Complementary and Alternative Medicine NIH - National Institutes of Health WHO - World Health Organisation US Pharmacopoeia

INDENA: A PROACTIVE VOICE Indena is an active member of all the relevant SECTOR ASSOCIATIONS: Assoerbe AESGP - Association Européenne des Spécialités Pharmaucetiques Grand Public CRN - Council for Responsible Nutrition CRN Japan - Council for Responsible Nutrition of Japan Federchimica/Gruppo Additivi Alimentari Japan Health Food & Nutrition Food Association JFAA - Japan Food Additives Association Kooperation Phytopharmaka - Germany HRF - Herb Research Foundation NNFA Japan - National Nutritional Foods Association Japan SIFIT - Società Italiana di Fitoterapia

A RESEARCH BASED COMPANY There are three sectors of excellence in Indena research: Process research: original advanced industrial production processes are designed and engineered for work on existing or new molecules, often on behalf of our partner companies Identification of new active principles derived from plants for pharmaceuticals, health foods and cosmetics Set up of proprietary formulations based on the combination of botanical derivatives

NEW CHALLENGING GOALS Our most recent research goal in the pharmaceutical sector is the licensing out of new patented molecules tested up to clinical phase I. Once our researchers have identified a new active principle, Indena: develops original manufacturing procedures validates the bulk production according to the international regulatory systems produces assessment and documentation of preclinical studies may carry out clinical phase I trials

MAIN PRODUCT CATEGORIES ISOLATED PURE PRODUCTS Pure molecules isolated from medicinal plants SELECTED ACTIVE PRINCIPLES Whole of natural substances belonging to the same chemical class STANDARDISED EXTRACTS Total extracts with a reproducible content of active or characteristic principles FORMULATED PREMIXES Bulk formulations of active principles ready for use FLUID EXTRACTS: Phytelene : Hydroglycolic extracts which contain the totum of the plant Cosmelene : Extracts with butylene glycol or butylene glycol and water PHYTOSOME Complexes of active principles and phospholipids

PHARMACEUTICAL MAIN PRODUCTS CATEGORIES - ISOLATED PURE PRODUCTS - SELECTED ACTIVE PRINCIPLES - STANDARDISED EXTRACTS - PHYTOSOME TYPICAL PRODUCTS Isolated pure products are at the cutting edge of our research and technological know-how. Isolated pure products are single highly purified molecules isolated from medicinal plants such as: PACLITAXEL 10-DAB III ESCIN COLCHICINE Anti-cancer Intermediate for Antioedema Antigout anti-cancers NICERGOLINE RESERPINE THIOCOLCHICOSIDE Nootropic Antihypertensive Muscle relaxant Indena is by far the major producer of FDA approved paclitaxel

HEALTH FOOD MAIN PRODUCTS CATEGORIES - SELECTED ACTIVE PRINCIPLES - STANDARDISED EXTRACTS - PHYTOSOME TYPICAL PRODUCTS Standardised extracts were introduced in the health food market by Indena more than 10 years ago. Some of our most important standardised extracts: BILBERRY GINSENG GRAPE SEED GREEN TEA (Mirtoselect ) (Ginselect ) (Leucoselect ) (Greenselect ) SAW PALMETTO SOYBEAN (Sabalselect ) (Soyselect ) Only Indena standardised extracts have full chemical characterization backed up by quality, safety and efficacy tests

SKIN & HAIR CARE MAIN PRODUCTS CATEGORIES - ISOLATED PURE PRODUCTS - SELECTED ACTIVE PRINCIPLES - STANDARDISED EXTRACTS - FORMULATED PREMIXES - FLUID EXTRACTS (Phytelene - Cosmelene ) - PHYTOSOME TYPICAL PRODUCTS Indena leverages its solid pharmaceutical background for the cosmetic field, developing functional ingredients with a wide range of applications for high skin & hair care products, such as the following lines: PHYTOSOME COSMELENE A complex of active principles and A new generation of functional, purified soybean phospholipids concentrated and standardised fluid extracts each designed to provide a specific benefit to the skin

BOTANICAL SOURCES In addition to the widespread traditional harvesting system of wild plants, Indena has established a world-wide network of plantations to provide its factories with high quality officinal plants. Internationally recognised botanical experts control more than 6,000 acres of Good Agricultural Practices (GAP) compliant plantations. Today more than 60% of the botanical raw material we use is grown in plantations. In their pursuit of the highest botanical standards and with maximum respect for the environment, our specialists conduct plant breeding operations on certain product lines. Plant tissue culture is used in the clonal propagation of high producing plants. This micropropagation offers an opportunity to achieve safe, high-quality plant stock, which is free from viral disease.

INDENA PRODUCTION FACTS & FIGURES Advanced and highly flexible state of the art technology is used throughout the entire Indena manufacturing cycle, guaranteeing: Compliance with Good Manufacturing Practices (GMP) Scale-up of new active principles, including those patented and licensed by clients Oncology units fully dedicated to the production of cytotoxic compounds Controlled area for final purification steps, HEPA filtered, fully validated Drying, finishing and packaging operations using glove box units Huge extraction capacity up to 20,000 metric tons of botanicals per year Health food pre-mixed formats (blending, granulation, capsule filling, tabletting, coating and packaging)

THE BIOTECHNOLOGY CHALLENGE Indena resources are dedicated to research and development in the following fields: - microbial fermentation and biotransformation - enzyme conversion - plant cell and tissue culture (fermentation and micropropagation) - protein technology - recombinant DNA Indena production expertise is focused on: - plant and microbial secondary metabolites - plant proteins and peptides This has led to the development of: - active pharmaceutical ingredients - active principles for generics - functional ingredients for nutraceuticals and cosmeceuticals

INDENA QUALITY SYSTEM The Indena Quality System is based on: QUALITY ASSURANCE QUALITY CONTROL The Indena Quality System ensures that all manufacturing, control and packaging processes comply with current Good Manufacturing Practices (GMP). Indena is approved by the FDA and by the Italian Ministry of Health. Customers such as international pharmaceutical companies may also conduct their own audits.

CUSTOMER ADVISORY SERVICE Indena develops a real partnership with its clients during all phases of a project: RESEARCH Co-development of new active principles FORMULATION DEVELOPMENT From high level consultancy to implementation : written formulation advice pre-mix sample preparations tablets, capsules, granules, creams, lotions and drink solutions samples PRE AND POST-SALE ASSISTANCE pre-sale consultancy and long term after-sale assistance analytical methods supply

MARKETING & COMMUNICATION Market trend analysis to launch and position new products New project selection based on R.O.I. (Return Of Investments) Scientific communication through: Partnership with universities to create and support post-graduate education in phytotherapy Participation in major scientific events and trade exhibitions Regular contributions to scientific, corporate and trade publications Fitoterapia, a journal founded in 1929 and today recognised world-wide as a premier source for the latest research on medicinal plants, now distributed by Elsevier

THE INDENA ORGANISATION HEADQUARTERS Indena S.p.A. - Milan - Italy SALES BRANCHES Indena France S.A.S. - Paris, France Indena S.A. - Barcelona, Spain Indena USA Inc. - Seattle, WA, USA Indena Japan Co. Ltd. - Tokyo, Japan

THE INDENA ORGANISATION PRODUCTION SITES Indena S.p.A. - Milan, Italy Indena S.p.A. - Settala (MI), Italy Bernett S.r.l. - Palestro (PV), Italy Indena S.A.S. - Tours, France Indena India Pvt. Ltd. - Bangalore, India Indena Madagascar S.A. - Fianarantsoa, Madagascar

SALES Worldwide Sales Network through Area Managers, Branches, Agents and Distributors in: - ARGENTINA - AUSTRALIA - AUSTRIA - BELGIUM - BRAZIL - CANADA - CHILE - COLOMBIA - DENMARK - EGYPT - FINLAND - FRANCE - GERMANY - GREECE - INDIA - INDONESIA - IRELAND - ISRAEL - JAPAN - JORDAN - MALAYSIA - MEXICO - NORWAY - POLAND - PORTUGAL - RUMANIA - RUSSIA - SOUTH AFRICA - SOUTH KOREA - SPAIN - SWEDEN - SWITZERLAND - TAIWAN - THAILAND - UKRAINE - UNITED KINGDOM - USA - VENEZUELA

HEADQUARTERS Viale Ortles, 12 20139 Milan - Italy tel. +39.02.574961 fax +39.02.57404620 www..com